Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On September 5, 2025, IR-Med, Inc. (the “Company”), entered into a series of amendments to its outstanding loan agre
. Unregistered Sales of Equity Securities. The information required by this Item 3.02 is included under Item 1.01 of this Current Report on Form 8-K. Item 9.01.